Cargando…

Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”

Detalles Bibliográficos
Autores principales:	Hiraide, Sakura, Komine, Keigo, Takahashi, Masanobu, Ishioka, Chikashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895766/ https://www.ncbi.nlm.nih.gov/pubmed/33547970 http://dx.doi.org/10.1007/s10147-021-01878-z

Ejemplares similares

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei
por: Hiraide, Sakura, et al.
Publicado: (2019)

Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer
por: Hiraide, Sakura, et al.
Publicado: (2021)

Pseudomyxoma Peritonei
por: Homeag, Maria, et al.
Publicado: (2009)

Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4)
por: Chen, Chin-Fan, et al.
Publicado: (2008)

Approach to pseudomyxoma peritonei
por: Rizvi, Syed Ali, et al.
Publicado: (2018)

lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma
por: Yamada, Hideharu, et al.
Publicado: (2021)

lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma
por: Yamada, Hideharu, et al.
Publicado: (2021)

Pseudomyxoma peritonei: An uncommon tumor
por: Gupta, Surabhi, et al.
Publicado: (2010)

Huge and Unique Pseudomyxoma Peritonei
por: Tjokroprawiro, Brahmana Askandar, et al.
Publicado: (2021)

Laparoscopic Mucin Removal in Patients with Pseudomyxoma Peritonei
por: Kotani, Yasushi, et al.
Publicado: (2009)

PSEUDOMYXOMA PERITONEI PRESENTING AS INGUINAL HERNIA
por: Campbell, Patrick, et al.
Publicado: (2009)

Pulmonary Metastasis from Pseudomyxoma Peritonei
por: Kitai, Toshiyuki
Publicado: (2012)

Clinicopathological features and prognosis of pseudomyxoma peritonei
por: WANG, HUAN, et al.
Publicado: (2014)

Novel Perspectives in Pseudomyxoma Peritonei Treatment
por: Sommariva, Antonio, et al.
Publicado: (2021)

Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
por: Campanati, Renato Gomes, et al.
Publicado: (2014)

Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei
por: Bjersand, Kathrine, et al.
Publicado: (2015)

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018)

Recurrent Incisional Hernia due to Pseudomyxoma Peritonei
por: Ergul, Zafer, et al.
Publicado: (2011)

Pseudomyxoma Peritonei Originating from an Intestinal Duplication
por: Lemahieu, Julie, et al.
Publicado: (2013)

Pseudomyxoma peritonei presenting as irreducible epigastric hernia
por: Gomes, Carina, et al.
Publicado: (2018)

A case of Pseudomyxoma Peritonei of an unexpected origin
por: Csanyi-Bastien, Marie, et al.
Publicado: (2021)

Appendiceal pseudomyxoma peritonei: unmasking the indolent invader
por: Jain, Anshini, et al.
Publicado: (2022)

Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
por: Imai, Hiroo, et al.
Publicado: (2022)

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach
por: Prabhu, Aruna, et al.
Publicado: (2020)

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
por: Imai, Hiroo, et al.
Publicado: (2018)

Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy
por: Haase, Erika, et al.
Publicado: (2009)

Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries
por: Yan, Fengcai, et al.
Publicado: (2020)

The Biological Synthesis and the Function of Mucin 2 in Pseudomyxoma Peritonei
por: Lin, Yu-Lin, et al.
Publicado: (2021)

Incidental Diagnosis of Pseudomyxoma Peritonei: A Case Report
por: Sarpietro, Giuseppe, et al.
Publicado: (2022)

The Role of Microorganisms in Appendiceal Pseudomyxoma Peritonei: A Review
por: Khamzina, Yekaterina, et al.
Publicado: (2022)

Under the Hood: Understanding the Features of Mucin in Pseudomyxoma Peritonei
por: Villarejo-Campos, Pedro, et al.
Publicado: (2023)

A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
por: Farquharson, A L, et al.
Publicado: (2008)

Pseudomyxoma peritonei: a clinical case of this poorly understood condition
por: de Oliveira, Ana Maria, et al.
Publicado: (2014)

A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei
por: Gilbreath, Jeremy J, et al.
Publicado: (2013)

Pseudomyxoma peritonei extending to the lower extremity: a case report
por: Joo, Min Wook, et al.
Publicado: (2015)

A New Etiology for the Abdominal Compartment Syndrome: Pseudomyxoma Peritonei
por: Sabbagh, Charles, et al.
Publicado: (2015)

Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP)
por: Pillai, Krishna, et al.
Publicado: (2017)

Molecular profiles of high‐grade and low‐grade pseudomyxoma peritonei
por: Noguchi, Rei, et al.
Publicado: (2015)

Endometriosis inflammation mimicking pseudomyxoma peritonei: A case report()
por: Medlin, Erin E., et al.
Publicado: (2016)

Pseudomyxoma Peritonei: Presentation of Two Cases and Challenging Issues in the Literature
por: Pantiora, Eirini V, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9ktupn5okuankf596s3dm2j76v